Quick Takeaways
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G/A for PRIME MEDICINE INC COMMON STOCK (PRME).
- Disclosed ownership: 3.3%.
- Date of event: 31 Dec 2025.
T. Rowe Price Investment Management, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for PRIME MEDICINE INC COMMON STOCK (PRME)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Security
- PRIME MEDICINE INC COMMON STOCK
- Symbol
- PRME
- Shares outstanding
- 181,672,212 shares
- Disclosed Ownership
- 5,995,183 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 10:28:31 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"T. Rowe Price Investment Management, Inc. disclosed 3.3% ownership in PRIME MEDICINE INC COMMON STOCK (PRME) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 10:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 3.3% | 5,995,183 | 5,995,183 | 0 | Ellen York | Vice President |